Biogen Inc
NASDAQ: BIIB
$160.38
+$2.69 (+1.7%)
Real Time Data Delayed 15 Min.
BIIB Articles
It seems that the thoughts of 24/7 Wall St. aren’t alone in the opinion of Amgen’s (NASDAQ:AMGN) future. In this morning’s issue of Business Week’s "Inside Wall Street" segment, George...
Published:
Last Updated:
ACAD started as Hold at Citigroup.ALB raised to Neutral at Goldman Sachs.AMB raised to Buy at B of A.APD cut to Neutral at Goldman Sachs.BAC started as Buy at Goldman Sachs.BDN cut to Neutral at B of...
Published:
Amgen Inc. (NASDAQ:AMGN) is seeing shares trade up another 2% pre-market after yesterday’s decision where an FDA panel rejected a proposal to set a specific target for red blood-cell levels in...
Published:
Last Updated:
Amgen (NASDAQ:AMGN) has a huge day ahead of it. The biotech giant is presenting data today on the appropriateuse of Erythropoiesis Stimulating Agents in Chronic RenalFailure patients to a joint...
Published:
Last Updated:
Amgen (NASDAQ:AMGN) has seen a slight recovery of late, mostly on reports that the U.S. Senate is asking Centers for Medicaid and Medicare Services to reconsider the drastically cut reimbursement...
Published:
Last Updated:
Stock Tickers: AXP, AMZN, BIIB, BNI, CME, DD, HAL, LMT, MRK, PEP, T These may not be the ONLY important earnings, but we wanted to hit most of the major earnings. It is hard to break-out this few...
Published:
Last Updated:
AYE raised to Buy at Jefferies.BIIB cut to Equal Weight at Lehman.CELG raised to Overweight at Lehman.CKNN started as Buy at Merriman Curhan Ford.CMG started as Equal-Weight at Lehman.DLB raised to...
Published:
Biogen Idec inc. (BIIB-NASDAQ) is trading up roughly 4% pre-market at $51.40, within striking distance of its $52.72 high over the last year on news of a share buyback plan. That is also the high...
Published:
(AAPL) Apple trading up 0.5% after Morgan Stanley raised its $110 target to $150.(BGP) Borders Group posted a -$0.51 EPS loss vs. -$0.38e.(BIIB) Biogen Idec announced up to $3 Billion in share...
Published:
Stock Tickers: AMGN, GILD, CELG, GENZ, MEDI, BIIB, AMLN, IMCL, DNDN, NFLD The short interest is on the rise overall, but the odd thing is that the short interest in biotech shares is really a mixed...
Published: